Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Capital Expenditures data on file, last reported at $51.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 21.54% year-over-year to $51.0 million; the trailing twelve-month figure through Mar 2026 stood at $262.0 million (up 39.36% YoY), and the FY2025 full-year result was $276.0 million, up 87.76% from the prior year.
• Capital Expenditures fell to $51.0 million in Q1 2026, from $62.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $92.0 million in Q3 2025 to a low of $7.0 million in Q1 2022.
• A 5-year average of $46.2 million and a median of $42.0 million in 2023 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 3700.0% in 2022, while the deepest fall reached 61.11% in 2022.
• Tracing ELAN's Capital Expenditures over 5 years: stood at $77.0 million in 2022, then slumped by 46.75% to $41.0 million in 2023, then advanced by 14.63% to $47.0 million in 2024, then soared by 31.91% to $62.0 million in 2025, then dropped by 17.74% to $51.0 million in 2026.
• Business Quant data shows ELAN's Capital Expenditures at $51.0 million in Q1 2026, $62.0 million in Q4 2025, and $92.0 million in Q3 2025.